TYMLOS 80 MG OPTIONS

It is named a specific therapy since it specifically targets the CD38  which can be overexpressed around the multiple myeloma cells. Daratumumab is from a class of medicines named CD38 monoclonal antibodies. These are typically biological products that have already been approved by the FDA, from which biosimilar products and solutions are as oppo